Skip to main content
. 2020 Mar 12;3(2):e00122. doi: 10.1002/edm2.122

Table 4.

Cox regression analyses of discontinuation of basal insulin

Baseline variables Unadjusted hazard ratio (95% CI) P‐value Adjusted hazard ratio (95% CI) a P‐value
Tertiary hospital vs Secondary hospital 1.136 (1.072‐1.204) <.0001 1.268 (1.192‐1.349) <.0001
Inpatient vs outpatient clinic 1.474 (1.388‐1.565) <.0001 1.317 (1.229‐1.411) <.0001
Age (y) 0.995 (0.992‐0.998) .0004 0.996 (0.993‐1.000) .0243
Education (vs Primary school or lower)
Junior high school 0.822 (0.764‐0.884) <.0001 0.843 (0.780‐0.912) <.0001
Senior high school 0.735 (0.679‐0.796) <.0001 0.801 (0.732‐0.877) <.0001
Junior college or higher 0.643 (0.586‐0.705) <.0001 0.713 (0.639‐0.796) <.0001
Urban residence vs rural residence 1.227 (1.155‐1.303) <.0001 0.925 (0.854‐1.002) .0556
Out‐of‐pocket ratio (%) 1.005 (1.004‐1.006) <.0001 1.004 (1.002‐1.005) <.0001
BMI group (kg/m2), (vs <24)
24‐27 0.969 (0.910‐1.033) .3331 1.062 (0.996‐1.134) .0671
≥28 1.099 (1.011‐1.195) .0263 1.154 (1.058‐1.258) .0012
Diabetes duration (y) 0.973 (0.967‐0.979) <.0001 0.972 (0.966‐0.978) <.0001
Times of SMBG per month before initiating BI (vs 0)
1‐5 0.868 (0.814‐0.927) <.0001 0.975 (0.911‐1.042) .4506
≥6 0.726 (0.671‐0.786) <.0001 0.910 (0.839‐0.988) .0243
Number of OAD types concomitant with BI (vs 0)
1 0.571 (0.532‐0.614) <.0001 0.847 (0.730‐0.982) .0275
≥2 0.547 (0.508‐0.589) <.0001 0.767 (0.586‐1.003) .0526
BI type (vs Glargine)
Detemir 0.958 (0.873‐1.052) .3679 0.918 (0.835‐1.009) .0763
NPH 1.742 (1.627‐1.864) <.0001 1.558 (1.443‐1.681) <.0001
Basal‐bolus insulin used at baseline (vs BI only) 2.319 (2.185‐2.461) <.0001 1.857 (1.706‐2.020) <.0001
a

Adjusted for all listed covariates.